Literature DB >> 27393770

Chronic Rhinosinusitis with Nasal Polyps.

Whitney W Stevens1, Robert P Schleimer2, Robert C Kern3.   

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is an important clinical entity diagnosed by the presence of both subjective and objective evidence of chronic sinonasal inflammation. Symptoms include anterior or posterior rhinorrhea, nasal congestion, hyposmia, and/or facial pressure or pain that last for a duration of more than 12 weeks. Nasal polyps are inflammatory lesions that project into the nasal airway, are typically bilateral, and originate from the ethmoid sinus. Males are more likely to be affected than females, but no specific genetic or environmental factors have been strongly linked to the development of this disorder to date. CRSwNP is frequently associated with asthma and allergic rhinitis, but the cellular and molecular mechanisms that contribute to the clinical symptoms are not fully understood. Defects in the sinonasal epithelial cell barrier, increased exposure to pathogenic and colonized bacteria, and dysregulation of the host immune system are all thought to play prominent roles in disease pathogenesis. Additional studies are needed to further explore the clinical and pathophysiological features of CRSwNP so that biomarkers can be identified and novel advances can be made to improve the treatment and management of this disease.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic rhinosinusitis; Chronic rhinosinusitis with nasal polyps; Nasal polyp

Mesh:

Substances:

Year:  2016        PMID: 27393770      PMCID: PMC4939220          DOI: 10.1016/j.jaip.2016.04.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  84 in total

1.  Association between severity of asthma and degree of chronic rhinosinusitis.

Authors:  David C Lin; Rakesh K Chandra; Bruce K Tan; Whitney Zirkle; David B Conley; Leslie C Grammer; Robert C Kern; Robert P Schleimer; Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2011 Jul-Aug       Impact factor: 2.467

2.  The relationship between atopy and chronic rhinosinusitis.

Authors:  Simon Robinson; Richard Douglas; Peter-John Wormald
Journal:  Am J Rhinol       Date:  2006 Nov-Dec

3.  CD4(+) and CD8(+) regulatory T cells in chronic rhinosinusitis mucosa.

Authors:  Harshita Pant; Amy Hughes; Mark Schembri; Dijana Miljkovic; Doreen Krumbiegel
Journal:  Am J Rhinol Allergy       Date:  2014 Mar-Apr       Impact factor: 2.467

4.  Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis.

Authors:  Joseph K Han; Bradley F Marple; Timothy L Smith; Andrew H Murr; Brent J Lanier; James W Stambaugh; Andrew S Mugglin
Journal:  Int Forum Allergy Rhinol       Date:  2012-05-01       Impact factor: 3.858

5.  Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Bruce K Tan; Quan-Zhen Li; Lydia Suh; Atsushi Kato; David B Conley; Rakesh K Chandra; Jinchun Zhou; James Norton; Roderick Carter; Monique Hinchcliff; Kathleen Harris; Anju Peters; Leslie C Grammer; Robert C Kern; Chandra Mohan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2011-10-13       Impact factor: 10.793

6.  Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment.

Authors:  Gretchen M Oakley; Karen Curtin; Quinn Orb; Carole Schaefer; Richard R Orlandi; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-12       Impact factor: 3.858

7.  Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis.

Authors:  S Seshadri; D C Lin; M Rosati; R G Carter; J E Norton; L Suh; A Kato; R K Chandra; K E Harris; H W Chu; A T Peters; B K Tan; D B Conley; L C Grammer; R C Kern; R P Schleimer
Journal:  Allergy       Date:  2012-07       Impact factor: 13.146

8.  T-cell regulation in chronic paranasal sinus disease.

Authors:  Nicholas Van Bruaene; Claudina Angela Pérez-Novo; Tomasz M Basinski; Thibaut Van Zele; Gabriele Holtappels; Natalie De Ruyck; Carsten Schmidt-Weber; Cezmi Akdis; Paul Van Cauwenberge; Claus Bachert; Philippe Gevaert
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

Review 9.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

10.  Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis.

Authors:  Monica Patadia; Julian Dixon; David Conley; Rakesh Chandra; Anju Peters; Lydia A Suh; Atsushi Kato; Roderick Carter; Kathleen Harris; Leslie Grammer; Robert Kern; Robert Schleimer
Journal:  Am J Rhinol Allergy       Date:  2010 Jan-Feb       Impact factor: 2.467

View more
  75 in total

Review 1.  Temporary olfactory improvement in chronic rhinosinusitis with nasal polyps after treatment.

Authors:  Dawei Wu; Benjamin S Bleier; Yongxiang Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-19       Impact factor: 2.503

2.  Nasal polyp fibroblasts modulate epithelial characteristics via Wnt signaling.

Authors:  Alex Dobzanski; Syed Muaz Khalil; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2018-08-17       Impact factor: 3.858

Review 3.  Current and Future Treatments of Rhinitis and Sinusitis.

Authors:  Gayatri B Patel; Robert C Kern; Jonathan A Bernstein; Park Hae-Sim; Anju T Peters
Journal:  J Allergy Clin Immunol Pract       Date:  2020-01-28

4.  YAP1 expression in nasal polyps and its relationship with epithelial mesenchymal transition.

Authors:  Jiabin Zhan; Huijuan Zhan; Jing Zheng; Xin Wei; Yihui Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.

Authors:  Jacqueline J Eastman; Kellen J Cavagnero; Adam S Deconde; Alex S Kim; Maya R Karta; David H Broide; Bruce L Zuraw; Andrew A White; Sandra C Christiansen; Taylor A Doherty
Journal:  J Allergy Clin Immunol       Date:  2017-03-06       Impact factor: 10.793

Review 6.  Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood.

Authors:  Hasan Yuksel; Ahmet Turkeli
Journal:  Tissue Barriers       Date:  2017-09-08

Review 7.  Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis.

Authors:  Yao Yao; Shumin Xie; Chunguang Yang; Jianhui Zhang; Xuewen Wu; Hong Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-01       Impact factor: 2.503

8.  Structural organization and cellular localization of tuftelin-interacting protein 11 (TFIP11).

Authors:  X Wen; Y-P Lei; Y L Zhou; C T Okamoto; M L Snead; M L Paine
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 9.  The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp.

Authors:  Tiancong Liu; Yang Sun; Weiliang Bai
Journal:  Curr Allergy Asthma Rep       Date:  2020-11-24       Impact factor: 4.806

10.  The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps.

Authors:  Lijie Jiang; Min Zhou; Jie Deng; Yueqi Sun; Kejun Zuo; Rui Zheng; Jianbo Shi; Yinyan Lai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-16       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.